Definitive Contract 75N93023C00029
Award Date 9/15/23
Potential Completion Date 9/14/25
Potential Value $1.8M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, has awarded a Small Business Innovation Research (SBIR) Phase I Definitive Contract with a ceiling value of $299,326.00 to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract requires Lynntech to design and develop a novel "3IN1" approach to efficiently collect samples (blood, sputum, urine) in field locations to support surveillance...
- This federal contract award, valued at $299,659.00, was granted to Big Eye Diagnostics Inc., a small business manufacturer of goods, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Small Business Innovation Research (SBIR) program and is a Definitive Contract with a Firm Fixed Price pricing type. The contract is for the development of an "easy-to-use, low-cost triplex RDT for the...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase II contract to Nowdiagnostics, Inc., a small disadvantaged business, for a multiplexed remote system for filovirus disease surveillance. The firm-fixed-price contract, with a potential value of $2,431,860.00, was awarded on September 20, 2018 and has a completion date of September 30, 2022....
- This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
- The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, awarded a $27,817.50 firm fixed-price purchase order to Lucid Scientific Inc., a small business contractor, to provide a Resipher 32X Starter Kit, annual software and maintenance, and Resipher 32X Lids. The contract has a completion date of November 30, 2023. The products will be delivered to an NIAID facility in Hamilton, Montana. The original solicitation was issued as a...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, awarded a $80,300.00 firm-fixed-price purchase order to Nanoscalelabs, LLC, a small business located in Fairfax, Virginia. The contract is for a Protein Printing System, with a period of performance within 60 days of the September 12, 2018 award date. The contract award was set aside for small businesses and originated from a competitive solicitation...
- The U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, valued at $223,568.00, is for the development of a "Simple, Inexpensive Unit for Removing Cells from Small Amounts of Blood in Resource-Limited Settings." This contract is a Firm Fixed Price...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, awarded a $10,650.00 firm fixed-price purchase order contract to Scale Biosciences, Inc. for the procurement of RNA kits. This contract has a total small business set-aside designation and a period of performance through December 31, 2024. As NIAID is responsible for conducting and supporting research to understand, treat, and prevent infectious diseases, this contract award is likely related to their...
- This SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) to Intuitive Biosciences Inc. for $299,855. The contract is associated with the NIH and Centers for Disease Control and Prevention (CDC) SBIR solicitation seeking proposals across numerous technical topics to advance public health goals through medical technologies, diagnostics, vaccines, cell therapies and other...
- This is a $300,000.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to Ividence Inc., a for-profit small business located in Hockessin, Delaware. The contract is for a Phase I Small Business Innovation Research (SBIR) program award, which is part of a larger SBIR solicitation from NIAID and the Centers for Disease Control and Prevention (CDC) covering a wide range...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), awarded a $1,799,353.00 Small Business Innovation Research (SBIR) Program Phase I contract to Redbud Labs, Inc., a for-profit microfluidic chip manufacturer. The contract is a firm fixed price definitive contract to implement extraction compatibility with whole blood and tissue lysates, producing a portable and rapidly installable instrument that meets industry biosafety standards including sterilization, for use in low resource environments. The work will be performed in Research Triangle Park, North Carolina from September 2023 through September 2026. This contract award is set aside for small businesses.
Generated 3/27/25, 9:54 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | $0 | 3/26/25 | |
| Not listed | Not listed | $1.8m | 9/15/23 |